SCHEMBL20537868

SCHEMBL20537868

COc1cc(C=Cc2cc(OC)c(OC)c(OC)c2)ccc1NC(=O)/C=C/c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 4/20 0.67
▸ MMP2 P08253 4/20 0.67
▸ MMP9 P14780 4/20 0.67
▸ EGFR P00533 1/20 0.67
▸ KDM4E B2RXH2 6/20 0.66
▸ ALDH1A1 P00352 6/20 0.66
▸ HPGD P15428 4/20 0.66
▸ NPSR1 Q6W5P4 2/20 0.66
▸ LMNA P02545 1/20 0.66
▸ GAA P10253 1/20 0.66
▸ TUBB4A P04350 2/20 0.64
▸ TUBB P07437 2/20 0.64
▸ TUBA3C P0DPH7 2/20 0.64
▸ TUBA1B P68363 2/20 0.64
▸ TUBA4A P68366 2/20 0.64
▸ TUBB4B P68371 2/20 0.64
▸ TUBB3 Q13509 2/20 0.64
▸ TUBB2A Q13885 2/20 0.64
▸ TUBB8 Q3ZCM7 2/20 0.64
▸ TUBA3E Q6PEY2 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20537865 1.00 MMP1 (0.67) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL20537870 1.00 MMP1 (0.67) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL20538423 0.94 ALDH1A1 (0.66) MMP1MMP2MMP9KDM4EALDH1A1
SCHEMBL20538421 0.94 ALDH1A1 (0.66) MMP1MMP2MMP9KDM4EALDH1A1
SCHEMBL20538205 0.92 KDM1A (0.65) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL20538202 0.92 KDM1A (0.65) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL20538207 0.92 KDM1A (0.65) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL20537650 0.92 TUBB4A (0.66) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL20537646 0.92 TUBB4A (0.66) MMP1MMP2MMP9EGFRKDM4E
SCHEMBL20537644 0.92 TUBB4A (0.66) MMP1MMP2MMP9EGFRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3183230-B1 N-((3,4,5-TRIMETHOXYSTYRYL)ARYL)CINNAMAMIDE COMPOUNDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2018-10-24 — — EP claimed
Send feedback